It has been shown that adipose tissue
hyperplasia (increased adipocyte number or adipogenesis) has beneficial effects on metabolic health. The aim of the present study was to determine whether
phytol could modulate
hyperplasia/adipogenesis and
glucose homeostasis, and to explore the underlying mechanisms in mice fed high-fat and high
fructose diet (HFFD). Our results demonstrated that
phytol administration decreased
body weight gain and inguinal subcutaneous white adipose tissue (iWAT) weight. However,
phytol significantly increased the adipocyte number in iWAT, with the smaller average adipocyte diameter. Meanwhile, OGTT result showed that
phytol improved
glucose tolerance. In accord,
phytol administration markedly increased expression of marker genes associated with adipogenesis (PPARγ and C/EBPα) and
glucose uptake (AS160 and GLUT4) and activated PI3K/Akt signaling pathway in mice iWAT. In agreement with the in vivo findings, the in vitro results indicated that 100 μM
phytol significantly enhanced 3T3-L1 adipogenesis and
glucose uptake, and activated PI3K/Akt signaling pathway. However,
phytol-induced enhancement of 3T3-L1 adipognesis and
glucose uptake, activation of PI3K/Akt signaling pathway, elevation of marker genes involved in adipogensis and
glucose uptake, as well as translocation of GLUT4 from cytoplasm to membrane were abolished by
Wortmannin, a specific PI3K/Akt inhibitor. Taken together,
phytol increased adipocyte number in iWAT and improved
glucose tolerance in mice fed HFFD, which was coincident with the enhanced adipogenesis and
glucose uptake in 3T3-L1, and was associated with activation of PI3K/Akt signaling pathway. These data suggested the application of
phytol as a potential nutritional agent to combat
obesity and
type 2 diabetes.